Target intelligence / Profile preview

N-methyl-D-aspartate receptor C-terminal domain–PDZ scaffold protein interface (NMDAR-PDZ interface)

Target
NMDAR-PDZ interface
Molecular classification
Protein-protein interaction interface, Ionotropic glutamate receptor complex, Scaffolding protein complex
01

Overview

The N-methyl-D-aspartate receptor (NMDAR) C-terminal domain–PDZ scaffold protein interface is a specialized protein-protein interaction (PPI) site that anchors NMDARs to the postsynaptic density and couples them to intracellular signaling pathways [1.1.2, 1.4.1]. The interface primarily involves the interaction between the C-terminal PDZ-binding motifs of NMDAR subunits, such as GluN2B, and the PDZ domains of scaffolding proteins like Postsynaptic Density Protein 95 (PSD-95) [1.1.3, 1.4.3]. This coupling is essential for physiological processes like synaptic plasticity, learning, and memory, but it also facilitates the recruitment of neuronal nitric oxide synthase (nNOS) [1.1.1, 1.5.2]. Under conditions of excitotoxicity, such as during an ischemic stroke, excessive NMDAR activation leads to overproduction of nitric oxide through this complex, causing neuronal death [1.2.2, 1.3.1]. Therapeutic agents like Nerinetide (NA-1) are designed to competitively inhibit this interface, thereby uncoupling NMDARs from toxic downstream signaling without blocking the receptor's essential ionotropic functions [1.2.3, 1.4.4]. This approach offers a neuroprotective strategy that avoids the severe side effects typically associated with direct NMDAR antagonists [1.3.4, 1.5.1]. Clinical development of inhibitors targeting this interface has primarily focused on acute ischemic stroke, where preserving neuronal viability during the reperfusion phase is critical [1.2.5].

Other names
NMDAR-PSD-95 interactionGluN2B-PSD-95 interfaceNMDAR-MAGUK interfaceNMDAR-PDZ interactionGluN2B-PSD-95 complex
02

Mechanism of action

Competitive inhibition of the protein-protein interaction between the NMDAR C-terminal PDZ-binding motif and the PDZ domains of scaffold proteins (primarily PSD-95). This uncouples the receptor from downstream neurotoxic signaling pathways, such as the activation of neuronal nitric oxide synthase (nNOS), without inhibiting the physiological ionotropic function of the NMDAR.

03

Biological functions

Synaptic plasticitySignal transductionExcitotoxicity regulationLearning and memoryNeuronal signaling
04

Disease associations

Ischemic strokeTraumatic brain injuryChronic painAlzheimer's diseaseHuntington's diseaseDepression
05

Safety considerations

Proteolytic degradation by plasmin (drug-drug interaction with alteplase)Potential disruption of physiological synaptic plasticityBlood-brain barrier permeability for peptide-based inhibitors
06

Interacting drugs

Nerinetide (NA-1)

3 more in the full profile.

07

Biomarkers

Brain-derived tau (BD-tau)Infarct volumeNitric oxide levelsPhospho-p38 MAPK levels

Beyond the preview

Go deeper on N-methyl-D-aspartate receptor C-terminal domain–PDZ scaffold protein interface (NMDAR-PDZ interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methyl-D-aspartate receptor C-terminal domain–PDZ scaffold protein interface (NMDAR-PDZ interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call